cdc494c60879d06d3cfb050372072e1b:f8d03fab15ac4647d8563a9fe9b1fd51b4a09571a2fb50602b8d24024928fe8eb3a7a4e414282eea80b54bbcd9e2646ce39b5e5170fc029463bced48b573d331fd13d2a310667eee9b31574231294d3e60e74244b2799a83f05b20a1711830d918b3d9622d56076037a75072fdf04fab309b3d042447e7b17411dd6101a0afec63841e2ce108595b366e9a1ac73e96a4872d05f52fdc79c2400d6fca859847309860d187e2c9fca4fe40119ea092f84f0b5e1187131c150a2dd7b0c05d487ddd03125630371daa8d4a84697385e466551d68dba383276168e879ea0640f3acc9b4df33c3310c1982518c2959d5deecdb57f21fdb34683e54937f50bfb95cbe2cb2103a979cf06a6938e0b36daee8b790ab6978e0fed5e593aebf2a49629991bcb23640bc69840b213603545bc6a5360dce7b4cf695655ba5c4369975eeb631b4439c46ea4b009eb2c3f16fc18467726da5d3a1ddc379838b06a92d83b12e403ea899e0b7a363aed5558fbb7e3e5a25d862024a4e8f0931be70155e596a26925dc16b0dbe8d5a980175ece06e3c01e909058945809a3c0d4f5ece4c22612cd64060db9a0405